These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
27. Clinical and genetic features of variegate porphyria in a Chinese patient. Chow KM; Hui CF; Lam CW; Morgan RR; Whatley SD; Kay R; Wong KS Chin Med J (Engl); 2001 Apr; 114(4):424-7. PubMed ID: 11780470 [No Abstract] [Full Text] [Related]
28. The use of dihydroxyacetone for photoprotection in variegate porphyria. Asawanonda P; Oberlender S; Taylor C Int J Dermatol; 1999 Dec; 38(12):916-8. PubMed ID: 10632771 [No Abstract] [Full Text] [Related]
29. Bile porphyrin analysis in the evaluation of variegate porphyria. Logan GM; Weimer MK; Ellefson M; Pierach CA; Bloomer JR N Engl J Med; 1991 May; 324(20):1408-11. PubMed ID: 2020296 [TBL] [Abstract][Full Text] [Related]
30. Unusual presentation of severe photosensitivity and neurodevelopmental delay in a consanguineous family. Al-Hage J; Nemer G; Kassabian P; Kurban M Clin Exp Dermatol; 2020 Jan; 45(1):117-119. PubMed ID: 30861571 [No Abstract] [Full Text] [Related]
31. Mutations in human CPO gene predict clinical expression of either hepatic hereditary coproporphyria or erythropoietic harderoporphyria. Schmitt C; Gouya L; Malonova E; Lamoril J; Camadro JM; Flamme M; Rose C; Lyoumi S; Da Silva V; Boileau C; Grandchamp B; Beaumont C; Deybach JC; Puy H Hum Mol Genet; 2005 Oct; 14(20):3089-98. PubMed ID: 16159891 [TBL] [Abstract][Full Text] [Related]
32. Homozygous variegate porphyria: identification of mutations on both alleles of the protoporphyrinogen oxidase gene in a severely affected proband. Frank J; McGrath J; Lam H; Graham RM; Hawk JL; Christiano AM J Invest Dermatol; 1998 Apr; 110(4):452-5. PubMed ID: 9540991 [TBL] [Abstract][Full Text] [Related]
33. A systematic study of the clinical and biochemical expression of variegate porphyria in a large South African family. Hift RJ; Meissner D; Meissner PN Br J Dermatol; 2004 Aug; 151(2):465-71. PubMed ID: 15327556 [TBL] [Abstract][Full Text] [Related]
34. Clinical and biochemical characteristics and genotype-phenotype correlation in Finnish variegate porphyria patients. von und zu Fraunberg M; Timonen K; Mustajoki P; Kauppinen R Eur J Hum Genet; 2002 Oct; 10(10):649-57. PubMed ID: 12357337 [TBL] [Abstract][Full Text] [Related]
35. Homozygous variegate porphyria: 20 y follow-up and characterization of molecular defect. Kauppinen R; Timonen K; von und zu Fraunberg M; Laitinen E; Ahola H; Tenhunen R; Taketani S; Mustajoki P J Invest Dermatol; 2001 Apr; 116(4):610-3. PubMed ID: 11286631 [TBL] [Abstract][Full Text] [Related]
36. Identification of a founder mutation in the protoporphyrinogen oxidase gene in variegate porphyria patients from chile. Frank J; Aita VM; Ahmad W; Lam H; Wolff C; Christiano AM Hum Hered; 2001; 51(3):160-8. PubMed ID: 11173967 [TBL] [Abstract][Full Text] [Related]
37. Total intravenous anesthesia in South-African genetic porphyria (variegate porphyria). Bichel T; Joris J; Jacquet N; Lamy M Acta Anaesthesiol Belg; 1993; 44(1):25-9. PubMed ID: 8342401 [TBL] [Abstract][Full Text] [Related]
38. [Acute hepatic porphyria and its neurological syndrome]. Bont A; Steck AJ; Meyer UA Schweiz Med Wochenschr; 1996 Jan; 126(1-2):6-14. PubMed ID: 8571113 [TBL] [Abstract][Full Text] [Related]
40. Overrepresentation of the founder PPOX gene mutation R59W in a South African patient with severe clinical manifestation of porphyria. de Villiers JN; Kotze MJ; van Heerden CJ; Sadie A; Gardner HF; Liebenberg J; van Zyl R; du Plessis L; Kimberg M; Frank J; Warnich L Exp Dermatol; 2005 Jan; 14(1):50-5. PubMed ID: 15660919 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]